UnitedHealth Group is a top dividend growth stock with strong financials and potential for 20%+ returns by 2026. Read more ...

We recently published a list of 8 Most Promising Healthcare Stocks According to Hedge Funds. In this article, we are going to ...

NEW YORK -- The Justice Department is suing to block UnitedHealth Group's $3.3 billion purchase of Amedisys, citing concerns ...

UnitedHealthcare overcomes challenges for long-term success, targets 13-16% earnings growth, presents buying opportunity with $700 price target by 2025.

Madison Investments, an investment advisor, released its “Madison Sustainable Equity Fund” third quarter 2024 investor letter ...

The U.S. Department of Justice and four state attorney generals filed an antitrust lawsuit against UnitedHealth Group on ...

The U.S. Department of Justice (DOJ) and four state attorneys general filed a lawsuit to block UnitedHealth Group’s (NYSE: ...

We can see that UnitedHealth Group Incorporated (NYSE:UNH) does use debt in its business. But the real question is whether this debt is making the company risky. Debt is a tool to help businesses ...

The agency argues the merger could lead to higher healthcare costs, particularly as Amedisys is a direct competitor to UnitedHealth’s LHC Group, which was acquired for $5.4 billion in 2022.

The Justice Department's lawsuit to block UnitedHealth Group's proposed $3.3 billion acquisition of Amedisys isn't changing the companies' views on combining. The Justice Department contends the ...

The Justice Department is suing to block UnitedHealth Group’s $3.3 billion purchase of Amedisys NEW YORK -- The Justice Department is suing to block UnitedHealth Group's $3.3 billion purchase of ...